Mark S. Graham

Array ( [id] => 5532944 [patent_doc_number] => 20090232732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk' [patent_app_type] => utility [patent_app_number] => 11/866475 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 50320 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232732.pdf [firstpage_image] =>[orig_patent_app_number] => 11866475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718639 [patent_doc_number] => 20080241161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'REMEDY FOR MAMMARY CANCER' [patent_app_type] => utility [patent_app_number] => 11/863679 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5097 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241161.pdf [firstpage_image] =>[orig_patent_app_number] => 11863679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272472 [patent_doc_number] => 20090076248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Plus end-directed microtubule motor required for chromosome congression' [patent_app_type] => utility [patent_app_number] => 11/895288 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21272 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076248.pdf [firstpage_image] =>[orig_patent_app_number] => 11895288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220018 [patent_doc_number] => 20100055113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR' [patent_app_type] => utility [patent_app_number] => 12/374787 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30934 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055113.pdf [firstpage_image] =>[orig_patent_app_number] => 12374787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230312 [patent_doc_number] => 20070292419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'TREATMENT WITH ANTI-ERBB2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/780640 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17532 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292419.pdf [firstpage_image] =>[orig_patent_app_number] => 11780640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718603 [patent_doc_number] => 20080241125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 11/781148 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33038 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241125.pdf [firstpage_image] =>[orig_patent_app_number] => 11781148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752561 [patent_doc_number] => 20080160636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same' [patent_app_type] => utility [patent_app_number] => 11/821459 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50429 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160636.pdf [firstpage_image] =>[orig_patent_app_number] => 11821459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177532 [patent_doc_number] => 07655239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated' [patent_app_type] => utility [patent_app_number] => 11/821574 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 29 [patent_no_of_words] => 17882 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655239.pdf [firstpage_image] =>[orig_patent_app_number] => 11821574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446062 [patent_doc_number] => 20090047288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity' [patent_app_type] => utility [patent_app_number] => 11/818697 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11632 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047288.pdf [firstpage_image] =>[orig_patent_app_number] => 11818697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687700 [patent_doc_number] => 20080031881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'MEDICAMENT FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 11/761264 [patent_app_country] => US [patent_app_date] => 2007-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5058 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031881.pdf [firstpage_image] =>[orig_patent_app_number] => 11761264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959029 [patent_doc_number] => 20110183416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Method of modulating the proliferation of medullary thyroid carcinoma cells' [patent_app_type] => utility [patent_app_number] => 11/810268 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8575 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183416.pdf [firstpage_image] =>[orig_patent_app_number] => 11810268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455294 [patent_doc_number] => 07892554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Internalizing ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/809773 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28698 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892554.pdf [firstpage_image] =>[orig_patent_app_number] => 11809773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920481 [patent_doc_number] => 08486412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Immunity to folate receptors' [patent_app_type] => utility [patent_app_number] => 12/303054 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9973 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493492 [patent_doc_number] => 20100209426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'INHIBITORS OF PROGASTRIN-INDUCED REPRESSION OF ICAT FOR TREATING AND/OR PREVENTING COLORECTAL CANCER, ADENOMATOUS POLYPOSIS OR METASTASIS DISPLAYING PROGASTRIN-SECRETING CELLS AND CELLS IN WHICH THE BETA-CATENIN/TCF-MEDIATED TRANSCRIPTIONAL PATHWAY IS CONSTITUTIVELY ACTIVE' [patent_app_type] => utility [patent_app_number] => 12/301661 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19053 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209426.pdf [firstpage_image] =>[orig_patent_app_number] => 12301661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797120 [patent_doc_number] => 20080008706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'B7S1: an immune modulator' [patent_app_type] => utility [patent_app_number] => 11/804398 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21750 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008706.pdf [firstpage_image] =>[orig_patent_app_number] => 11804398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375792 [patent_doc_number] => 08680056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Antiproliferative factor and methods of use' [patent_app_type] => utility [patent_app_number] => 11/743865 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 25032 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11743865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004533 [patent_doc_number] => 20070202101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Combination therapy using anti-EGFR antibodies and anti-hormonal agents' [patent_app_type] => utility [patent_app_number] => 11/789883 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14333 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202101.pdf [firstpage_image] =>[orig_patent_app_number] => 11789883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004964 [patent_doc_number] => 20070202534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia' [patent_app_type] => utility [patent_app_number] => 11/796405 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8758 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202534.pdf [firstpage_image] =>[orig_patent_app_number] => 11796405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285361 [patent_doc_number] => 20090099036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR SCREENING GLYCAN STRUCTURES' [patent_app_type] => utility [patent_app_number] => 12/297384 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16729 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099036.pdf [firstpage_image] =>[orig_patent_app_number] => 12297384 [rel_patent_id] =>[rel_patent_doc_number] =>)